Although there are no specific studies directly focusing on CLIC1 inhibitors for CIRI, previous studies [25,27,56] have suggested CLIC1 as a potential therapeutic target for central nervous system diseases, such as neurodegenerative diseases and ischemic stroke. This evidence concerns the gene CLIC1 and neurodegenerative disease.